March 4 (Reuters) - Mira Pharmaceuticals Inc MIRA.O:
MIRA PHARMACEUTICALS ANNOUNCES APPROVAL AND INITIATION OF PHASE 1 CLINICAL TRIAL FOR KETAMIR-2 IN NEUROPATHIC PAIN
Source text: [ID:n0001493152-25-008977]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.